20 Jan Cellular Logistics Announces New Funding for Potency Assay Development to Advance CFX Regenerative Therapy
MADISON, Wis., January 20, 2026 – Cellular Logistics Inc., a pioneering Madison-based biotechnology company dedicated to transforming the treatment of heart disease through innovative regenerative medicine, today announced the receipt of new funding specifically earmarked for the development of potency assays critical to its flagship...